Medicare Rebates

Nicola is a Clinical Audiologist who accepts referrals using Medicare item number 10952, for the treatment for Tinnitus, Hyperacusis and / or Misophonia. This consists of 5 sessions of evidence-based and specialised Cognitive Behavioural Therapy sessions lasting 50 minutes. Nicola does not sell hearing aids, and patients can be referred with peace of mind because treatment does not include the sale of expensive hearing aids. Referral to a Hearing Aid clinic will be provided if appropriate. Nicola also utilises Sound Therapy, Psychoeducation and Communication Skills training.

Relevant research



Aazh, H. & Allott, R. 2016. Cognitive behavioural therapy in management of hyperacusis: a narrative review and clinical implementation. Auditory and Vestibular Research, 25, 63-74.

Aazh, H., Bryant, C. & Moore, B.C.J. 2020a. Patients’ perspectives about the acceptability and effectiveness of audiologist-delivered cognitive behavioral therapy for tinnitus and/or hyperacusis rehabilitation. American Journal of Audiology, 28, 973-985.

Aazh, H., Danesh, A. & Moore, B.C.J. 2020b. Internal Consistency and Convergent Validity of the Inventory of Hyperacusis Symptoms Ear & Hearing, [in press],

Aazh, H., Landgrebe, M., Danesh, A. & Moore, B.C.J. 2019. Cognitive behavioral therapy for alleviating the distress caused by tinnitus, hyperacusis and misophonia: Current perspectives. Psychology Research and Behavior Management 23, 991-1002.

Aazh, H. & Moore, B.C.J. 2017. Factors related to Uncomfortable Loudness Levels for patients seen in a tinnitus and hyperacusis clinic. International Journal of Audiology 56, 793-800.

Aazh, H. & Moore, B.C.J. 2018a. Effectiveness of audiologist-delivered cognitive behavioral therapy for tinnitus and hyperacusis rehabilitation: outcomes for patients treated in routine practice   American Journal of Audiology, 27, 547-558.

Aazh, H. & Moore, B.C.J. 2018b. Proportion and characteristics of patients who were offered, enrolled in and completed audiologist-delivered cognitive behavioural therapy for tinnitus and hyperacusis rehabilitation in a specialist UK clinic. International Journal of Audiology, 57, 415-425.

Adamchic, I., Langguth, B., Hauptmann, C. & Tass, P.A. 2012. Psychometric evaluation of visual analog scale for the assessment of chronic tinnitus.  . American Journal of Audiolgy 21, 215-225.

Bastien, C.H., Vallieres, A. & Morin, C.M. 2001. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Medicine, 2, 297-307.

Connor, K.M., Kobak, K.A., Churchill, L.E., Katzelnick, D. & Davidson, J.R. 2001. Mini-SPIN: A brief screening assessment for generalized social anxiety disorder. Depress Anxiety, 14, 137-40.

Crittendon, J. & Hopko, D.R. 2006. Assessing worry in older and younger adults: Psychometric properties of an abbreviated Penn State Worry Questionnaire (PSWQ-A). J Anxiety Disord, 20, 1036-54.

Foa, E.B., Huppert, J.D., Leiberg, S., Langner, R., Kichic, R. et al 2002. The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess, 14, 485-96.

Greenberg, B. & Carlos, M. 2018. Psychometric Properties and Factor Structure of a New Scale to Measure Hyperacusis: Introducing the Inventory of Hyperacusis Symptoms. Ear Hear, 39, 1025-1034.

Houck, P.R., Spiegel, D.A., Shear, M.K. & Rucci, P. 2002. Reliability of the self-report version of the panic disorder severity scale. Depress Anxiety, 15, 183-5.

Khalfa, S., Dubal, S., Veuillet, E., Perez-Diaz, F., Jouvent, R. et al 2002. Psychometric normalization of a hyperacusis questionnaire. Journal for Oto-rhino-laryngology and its Related Specialties, 64, 436-42.

Kroenke, K., Spitzer, R.L. & Williams, J.B. 2001. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med, 16, 606-13.

Newman, C.W., Sandridge, S.A. & Jacobson, G.P. 1998. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol, 9, 153-60.

Salkovskis, P.M., Rimes, K.A., Warwick, H.M. & Clark, D.M. 2002. The Health Anxiety Inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med, 32, 843-53.

Spitzer, R.L., Kroenke, K., Williams, J.B. & Lowe, B. 2006. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med, 166, 1092-7.